Henry Schein (HSIC) Competitors

Cardinal Health (NYSE:CAH) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk, community ranking and dividends.

Which has higher earnings & valuation, CAH or HSIC?

Cardinal Health has higher revenue and earnings than Henry Schein. Cardinal Health is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$226.83B	0.13	$852M	$5.14	24.04
Henry Schein	$12.34B	0.81	$416M	$2.43	32.92

Do institutionals & insiders hold more shares of CAH or HSIC?

87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.1% of Cardinal Health shares are held by company insiders. Comparatively, 1.1% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Which has more risk & volatility, CAH or HSIC?

Cardinal Health has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500.

Is CAH or HSIC more profitable?

Henry Schein has a net margin of 2.51% compared to Cardinal Health's net margin of 0.56%. Henry Schein's return on equity of 12.90% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.56%	-56.56%	4.13%
Henry Schein	2.51%	12.90%	5.21%

Does the media refer more to CAH or HSIC?

In the previous week, Cardinal Health had 9 more articles in the media than Henry Schein. MarketBeat recorded 48 mentions for Cardinal Health and 39 mentions for Henry Schein. Cardinal Health's average media sentiment score of 0.95 beat Henry Schein's score of 0.31 indicating that Cardinal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardinal Health	20 Very Positive mention(s)	6 Positive mention(s)	17 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	9 Very Positive mention(s)	2 Positive mention(s)	19 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community believe in CAH or HSIC?

Cardinal Health received 543 more outperform votes than Henry Schein when rated by MarketBeat users. Likewise, 71.56% of users gave Cardinal Health an outperform vote while only 51.71% of users gave Henry Schein an outperform vote.

Company	Underperform	Outperform
Cardinal Health	Outperform Votes 921 71.56%	Underperform Votes 366 28.44%
Henry Schein	Outperform Votes 378 51.71%	Underperform Votes 353 48.29%

Do analysts rate CAH or HSIC?

Cardinal Health presently has a consensus price target of $135.64, indicating a potential upside of 9.78%. Henry Schein has a consensus price target of $80.10, indicating a potential upside of 0.12%. Given Cardinal Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Cardinal Health is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	0 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.73
Henry Schein	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.58

Summary

Cardinal Health beats Henry Schein on 10 of the 19 factors compared between the two stocks.